Improved Quality of Life , Clinicians showing examples of Trial Patients Responding to Treatment positively..
Patients would drop out of the trial had SNT 5505 delivered a detrimental effect on their Health ,
Reduction in Spleen size ....
We believe we have a competitive Profile and a Valuable Treatment....
Positive Phase II Data delivering confidence to clinicians and Trial Patients ....
Patients getting better from longer exposure ....
Update in March 2025...
Time for an Afternoon Latte
NZT
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.004(7.02%) |
Mkt cap ! $86.12M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 4.9¢ | $5.887M | 127.7M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 107994 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| SNT (ASX) Chart |